Member Info for Jimzi

Suggest you go through the last 6 month posts here where it is all laid out.

Because the majority shareholder plays fast and loose abusing his [and family] control.

Trust has gone. Hence we are here.

Agreed - looks to me it's the remaining placing flippers - they are still in profit. Disappointing but thats the market we are in

Problem is there are 100’s of trial wannabes both here and more so in the US. It’s a punt whether it’s picked , not an investment. Nothing wrong with a punt as long as you can take the RR . Frankly it could be 20p or private ( TB won’t lose face!)

Too add, I remember some mocking the risk in Morocco- it’s one of the best legal and foreign friendly emerging countries . Anyway, sell, buy or watch, it will be 100% interesting 😎

Your strange. You research companies on their merits, not the bourse they are on. Every bourse has crap, hardly affects decent ones. That’s called stock picking. Dunno why a few are having mini meltdowns. Cash + prospects =?

Just keep posting about the IPR. Your extensive knowledge has been noted 😂😂

Many shares just re rate with no news. Check the risers with no RNS. It’s an investment- so invest, not guess the re rate day.

How many shares would you like to have?

Shows why having an independent [100% net margin] revenue stream is an excellent way to reduce risk - and prospects.

CMRS is the only junior to be savvy enough and able to do this. And peeps sell cause they are bored.

Anyone who says they bought right at the bottom are either lucky or telling porkies - esp with low floaters.

This is THE average cost share - you can't buy 400k in one go.

Added 20k SB at 9.88.

Take advantage of the low liquidity traders.

Hence they are planning to double production.

They used to do RNS-R's.

Phase 2, phase 3, FDA - your looking at years and of course high risk.

The easy bit has been done - any partner knows this.

Tend to agree - he talks alot - was supposed to have a game changing shareholder value event last Aug etc but no hard information then or since.

Is just me that is astonished peeps are selling and we are basically at the placing price with such a seismic factual independent endorsement from the industry we are selling to? [with a totally uncontentious product that every stakeholder loves]

That RNS made us the best risk/reward play in all UK markets imo [maybe because RNS still not showing on LSE?]

Like the steady as we go approach .Agree from an operational angle - its been thought out meticulously - as has expanded production - its all very professional and reassuring.

But what the market has missed is the mcap / value angle. With 40% savings, it will change a large section of the home insurance market globally.

I am gob smacked that the magnitude of that independent report/presentation has not sunk in yet. ONDO has a legal monopoly and recurring revenue business model. That's the holy grail.

@StockBoxMedia

spoke to Craig Foster CEO

@OndoPlc

alongside Andreas from Länsförsäkringar,where they shared their experiences and successes at the

@ITCDIAEurope

conference yesterday.

➡️ Craig reflected on the growth and impact of their flagship product, #LeakBot. Introduced five years ago at this very conference! LeakBot has significantly reduced water damage claims and operational costs for their partners.

Watch below ⬇️

https://youtube.com/watch?v=2ZdjsPoOjGw

From DEST post

One after the other biotech (AVCT, GDR, FAR and others) and others are going for placings.

Here, no placing for years ( the pain has already been endured) no warrants , 60m shares and an EV of around £3.5m - and you can still buy below last placing with updates soon.

Adds up to lower risk with high reward. Or at least, not a heart attack share, likely to be profitable H2 without the big one

FYI. Sells were at 15.34 and buys 15.3 in last half hour.

And the 16.50 UT means we open down 6% on opening , it’s in play 😎